Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study
维奈托克联合阿扎胞苷治疗NPM1或CBF AML患者强化化疗后分子复发:一项FILO研究
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01344-3
Higué, Jules; Orvain, Corentin; Dumas, Pierre-Yves; Peterlin, Pierre; Hospital, Marie-Anne; Barrière, Sabrina; Couturier, Audrey; Carre, Martin; Chantzi, Areti; Tavernier, Emmanuelle; Delabesse, Éric; Bidet, Audrey; Bouvier, Anne; Mozziconacci, Marie-Joelle; Véronèse, Lauren; Pastoret, Cédric; Tondeur, Sylvie; Flandrin-Gresta, Pascale; Lachot, Sébastien; Cazaux, Marine; Thépot, Sylvain; Forcade, Edouard; Chevallier, Patrice; Devillier, Raynier; Aspas Requena, Gaspar; Bertoli, Sarah; Pigneux, Arnaud; Récher, Christian